BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37247177)

  • 1. Fecal microbiota transplant delivered via invasive routes in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Mohan BP; Loganathan P; Khan SR; Garg G; Muthusamy A; Ponnada S; Pasam RT; Chandan S; Tuteja A
    Indian J Gastroenterol; 2023 Jun; 42(3):315-323. PubMed ID: 37247177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome.
    Ianiro G; Eusebi LH; Black CJ; Gasbarrini A; Cammarota G; Ford AC
    Aliment Pharmacol Ther; 2019 Aug; 50(3):240-248. PubMed ID: 31136009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Xu D; Chen VL; Steiner CA; Berinstein JA; Eswaran S; Waljee AK; Higgins PDR; Owyang C
    Am J Gastroenterol; 2019 Jul; 114(7):1043-1050. PubMed ID: 30908299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
    Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
    Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Jamshidi P; Farsi Y; Nariman Z; Hatamnejad MR; Mohammadzadeh B; Akbarialiabad H; Nasiri MJ; Sechi LA
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials.
    Wu J; Lv L; Wang C
    Front Cell Infect Microbiol; 2022; 12():827395. PubMed ID: 35295757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Wang M; Xie X; Zhao S; Ma X; Wang Z; Zhang Y
    Front Immunol; 2023; 14():1136343. PubMed ID: 37275867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis.
    Myneedu K; Deoker A; Schmulson MJ; Bashashati M
    United European Gastroenterol J; 2019 Oct; 7(8):1033-1041. PubMed ID: 31662860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review, pairwise meta-analysis and network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in irritable bowel syndrome.
    Rokkas T; Hold GL
    Eur J Gastroenterol Hepatol; 2023 Apr; 35(4):471-479. PubMed ID: 36719820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
    Halkjær SI; Lo B; Cold F; Højer Christensen A; Holster S; König J; Brummer RJ; Aroniadis OC; Lahtinen P; Holvoet T; Gluud LL; Petersen AM
    World J Gastroenterol; 2023 May; 29(20):3185-3202. PubMed ID: 37346153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome Patients: An Updated Systematic Review and Meta-Analysis.
    Elhusein AM; Fadlalmola HA
    Gastroenterol Nurs; 2022 Jan-Feb 01; 45(1):11-20. PubMed ID: 35108241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of fecal microbiota transplantation for irritable bowel syndrome.
    El-Salhy M; Hausken T; Hatlebakk JG
    Neurogastroenterol Motil; 2021 Nov; 33(11):e14157. PubMed ID: 34236740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
    Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
    Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome.
    Lahtinen P; Jalanka J; Hartikainen A; Mattila E; Hillilä M; Punkkinen J; Koskenpato J; Anttila VJ; Tillonen J; Satokari R; Arkkila P
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1321-1331. PubMed ID: 32343000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study.
    Holster S; Lindqvist CM; Repsilber D; Salonen A; de Vos WM; König J; Brummer RJ
    Clin Transl Gastroenterol; 2019 Apr; 10(4):e00034. PubMed ID: 31009405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
    Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
    [No Abstract]   [Full Text] [Related]  

  • 17. Fecal microbiota transplantation in patients with irritable bowel syndrome: an overview of current studies.
    Körner E; Lorentz A
    J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36882216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan.
    Hamazaki M; Sawada T; Yamamura T; Maeda K; Mizutani Y; Ishikawa E; Furune S; Yamamoto K; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Nakamura M; Fujishiro M
    BMC Gastroenterol; 2022 Jul; 22(1):342. PubMed ID: 35836115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials.
    Zhao HJ; Zhang XJ; Zhang NN; Yan B; Xu KK; Peng LH; Pan F
    Front Nutr; 2022; 9():890357. PubMed ID: 35719141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
    Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM
    Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.